NIKKEI 225
27,883.78 +365.53 (+1.33%) HANG SENG
20,192.40 +407.75 (+2.06%) CRUDE OIL
72.93 -0.27 (-0.37%) GOLD FUTURES
1,966.70 -6.80 (-0.34%) DOW
32,695.38 +301.13 (+0.93%) Bitcoin GBP
23,047.94 +905.81 (+4.09%)
GH Dec 2023 75.000 call
| Previous close | 8.50 |
| Open | 8.50 |
| Bid | 0.15 |
| Ask | 1.35 |
| Strike | 75.00 |
| Expiry date | 2023-12-15 |
| Day's range | 8.50 - 8.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
- Zacks
Here's Why Guardant Health (GH) Looks Ripe for Bottom Fishing
Guardant Health (GH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Business Wire
Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence
PALO ALTO, Calif., March 21, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced support for an investigator initiated study led and conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening. In this study, The Ohio State University Guardant Shield Colorectal Canc
- Simply Wall St.
In the wake of Guardant Health, Inc.'s (NASDAQ:GH) latest US$536m market cap drop, institutional owners may be forced to take severe actions
Key Insights Institutions' substantial holdings in Guardant Health implies that they have significant influence over...
